ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Metabolism >Transferase Inhibitors >LONAFARNIB

LONAFARNIB

LONAFARNIB Structure
CAS No.
193275-84-2
Chemical Name:
LONAFARNIB
Synonyms
Sarasar;Sch66336;Sch 66336;EOS-61911;LONAFARNIB;LonafarMib;SCH-066336;Unii-iow153004f;Lonafarnib [usan];Valine Impurity 114
CBNumber:
CB31011743
Molecular Formula:
C27H31Br2ClN4O2
Molecular Weight:
638.82
MOL File:
193275-84-2.mol
MSDS File:
SDS
Modify Date:
2023/12/27 10:21:05

LONAFARNIB Properties

Melting point 214.5-215.9° (monohydrate); mp 222-223°
alpha D25 = +49.1° (c = 0.21 in methanol)
Boiling point 710.4±70.0 °C(Predicted)
Density 1.536
storage temp. -20°C
solubility Chloroform (Slightly), Methanol (Slightly)
pka 15.76±0.40(Predicted)
form powder
color white to beige

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P261-P264-P271-P280-P302+P352-P305+P351+P338

LONAFARNIB price More Price(2)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) SML1457 Lonafarnib ≥98% (HPLC) 193275-84-2 5MG ₹13531.25 2022-06-14 Buy
Sigma-Aldrich(India) SML1457 Lonafarnib ≥98% (HPLC) 193275-84-2 25MG ₹54428.1 2022-06-14 Buy
Product number Packaging Price Buy
SML1457 5MG ₹13531.25 Buy
SML1457 25MG ₹54428.1 Buy

LONAFARNIB Chemical Properties,Uses,Production

Uses

Lonafarnib is an orally bioavailable tricyclic inhibitor of farnesyl protein transferase. It inhibits Rheb farnesylation and mTOR signaling and enhances taxane and tamoxifen antitumor activity. Studies show that it induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells

Definition

ChEBI: A 4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamide that has R configuration. It is used as oral farnesyltransferase nhibitor.

General Description

Lonafarnib (SCH66336) is a farnesyl transferase inhibitor (FTI). K- and N-Ras are substrates of farnesyl transferase.

Mechanism of action

Lonafarnib is a protein farnesyltransferase inhibitor (FTI) that reversibly binds to the farnesyltransferase CAAX binding site9, thereby inhibiting progerin farnesylation and subsequent intercalation into the nuclear membrane.

Side effects

  • vomiting
  • diarrhea
  • nausea
  • stomach pain
  • constipation
  • gas
  • decreased appetite
  • decreased weight

LONAFARNIB Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 149)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29898 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Chongqing Chemdad Co., Ltd +86-023-6139-8061 +86-86-13650506873 China 39916 58 Inquiry
CONIER CHEM AND PHARMA LIMITED +8618523575427 China 49391 58 Inquiry
Dideu Industries Group Limited +86-29-89586680 +86-15129568250 China 24639 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry

Related articles

  • How is Lonafarnib synthesised?
  • Lonafarnib was synthesised starting from the bromination of chloroanthranilic acid and using the lonafarnib precursor tricycle....
  • Dec 27,2023

LONAFARNIB Spectrum

LONAFARNIB 4-(2-(4-((R)-3,10-dibroMo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)cyclohexyl)-2-oxoethyl)piperidine-1-carboxaMide Lonafarnib (SCH66336) 1-Piperidinecarboxamide, 4-(2-(4-((11R)-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-B)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)- 4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-B)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide Lonafarnib [usan] Sarasar Sch 66336 Sch66336 Unii-iow153004f 4-[2-[4-[(11R)-3,10-DibroMo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1- 1-PiperidinecarboxaMide, 4-[2-[4-[(11R)-3,10-dibroMo-8-chloro-6 LonafarMib (R)-4-(2-(4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl)-2-oxoethyl)piperidine-1-carboxamide ( )4-(2-(4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta (1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxami de 4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide SARASAR; SCH 66336; SCH66336; SCH-66336 EOS-61911 SCH-066336 LONAFARNIB USP/EP/BP Lonafarnib Sarasar SCH 66336 Valine Impurity 114 193275-84-2 Inhibitor Aromatics Heterocycles Inhibitors Intermediates & Fine Chemicals Pharmaceuticals APIs